Pulmonary Delivery: Innovative Approaches and Perspectives

  title={Pulmonary Delivery: Innovative Approaches and Perspectives},
  author={Carlotta Marianecci and Luisa Di Marzio and Federica Rinaldi and Maria Carafa and Franco Alhaique},
  journal={Journal of Biomaterials and Nanobiotechnology},
The respiratory system, as well as the skin, are organs in direct contact with the environment and it they represent possible doors for the entrance of therapeutic agents into the body. Because of the increasing incidence of pulmonary diseases with high mortality and morbidity, pulmonary drug delivery is emerging as a non-invasive and attractive approach for the treatment of several pathologies. It must be pointed out that the development of drug delivery systems for pulmonary application… 

Figures from this paper

A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections.
Nanotechnology combined with direct administration to the airways using commercially available delivery devices, is a highly attractive formulation strategy to eradicate microorganisms from the lower respiratory tract, which might otherwise present opportunities for multi-drug resistance.
Nanotechnological applications for the control of pulmonary infections
Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseases
Theranostic nanoparticles with both therapeutic and imaging abilities have the promise to revolutionize diagnosis, therapy, and prognosis and could potentially be translated into clinical advances to improve diagnosis and treatment of chronic respiratory diseases and enhance quality of life for the patients.
Aerosol Therapy Development and Methods of Increasing Nebulization Effectiveness
The atomization process in medical nebulizers is analyzed and it is concluded that nebulization of drugs constitutes an effective method in drug delivery to the respiratory system and can be widely implemented in medicine.
Trends in Nanotechnology for Practical Applications
Response Surface Methodology for Development and Optimization of Theophylline Pulmonary Delivery System
The aim of the present study was to develop theophylline (TP) inhalable sustained delivery system by preparing solid lipid microparticles using glyceryl behenate (GB) and poloxamer 188 (PX) as a


Nanomedicine in pulmonary delivery
This review focuses on the current status and explores the potential of colloidal carriers (ie, nanocarrier systems) in pulmonary drug delivery with special attention to their pharmaceutical aspects.
Pulmonary drug delivery systems: recent developments and prospects.
In addition to the various advances made in the field of pulmonary-route administration, new systems based on perfluorooctyl bromide are described, which guarantee oxygen delivery in the event of respiratory distress and drug delivery into the lungs.
Targeted delivery of nanoparticles for the treatment of lung diseases.
Non-phospholipid vesicles for pulmonary glucocorticoid delivery.
Pulmonary delivery of therapeutic siRNA
Inhalation, deposition, and fate of insulin and other therapeutic proteins.
  • J. Brain
  • Biology
    Diabetes technology & therapeutics
  • 2007
The lungs are ideally suited for the delivery of polypeptides and proteins to the systemic circulation and a substantial fraction is transported across the air-blood barrier into the blood, where it continues to be biologically active.
Inhaled nanoparticles--a current review.
Inhaling medicines: delivering drugs to the body through the lungs
Advances in lung physiology and formulation composition that influence the systemic delivery of inhaled therapeutics are reviewed.